NCT02567721 - Post-authorisation Safety Study (PASS) of Influenza Vaccine in United Kingdom (UK) | Biotech Hunter

Enrollment

11,530

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions

Influenza

Interventions

OTHER

Vaccine safety surveillance

Extraction of routinely collected primary care data from nine GP practices and an active surveillance approach in 3 of the 9 GP practices, by using an existing card-based ADR reporting system (MHRA Yellow Card), to estimate proportions of AEIs among seasonal influenza-vaccinated individuals.

Trial Locations (1)

GU2 7XH

GSK Investigational Site, Surrey